+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
HALEOSLABS

Haleos Labs Share Price

 

 

Haleos Labs live price: ₹1410.2. It opened at ₹1,466 vs previous close ₹1,449; intraday high/low: ₹1,475/₹1,380. The 50 & 200 DMA stand at ₹1,441.20/₹1,329.49.

Haleos Labs Performance

  • Today's Low
  • ₹1,380
  • Today's High
  • ₹1,475
  • 52 Week Low
  • ₹1,067
  • 52 Week High
  • ₹1,774
  • Open Price₹1,466
  • Previous Close₹1,449
  • Volume2,512
  • 50 DMA₹1,441.20
  • 100 DMA₹1,392.08
  • 200 DMA₹1,329.49

Haleos Labs Chart

Investment Returns

  • Over 1 Month -7.15%
  • Over 3 Month + 12.62%
  • Over 6 Month + 14.43%
  • Over 1 Year + 25.03%

Smart Investing Starts Here Start SIP with Haleos Labs for Steady Growth!

Invest Now

Haleos Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.6
  • PEG Ratio
  • -1.8
  • Market Cap Cr
  • 426
  • P/B Ratio
  • 2
  • Average True Range
  • 87.31
  • EPS
  • 57.26
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -21.32
  • RSI
  • 45.17
  • MFI
  • 35.49

Haleos Labs Financials

Haleos Labs Technicals

EMA & SMA

Current Price
₹1,410.20
-38.3 (-2.64%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹1,446.60
  • 50 Day
  • ₹1,441.20
  • 100 Day
  • ₹1,392.10
  • 200 Day
  • ₹1,329.50

Resistance and Support

1421.77 Pivot Speed
  • R3 1,558.33
  • R2 1,516.67
  • R1 1,463.43
  • S1 1,368.53
  • S2 1,326.87
  • S3 1,273.63

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Haleos Labs Ltd has an operating revenue of Rs. 333.79 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 8% is okay, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 23%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 11% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -5% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 32 which is a POOR score indicating inconsistency in earnings, a RS Rating of 78 which is FAIR indicating the recent price performance, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 67 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Haleos Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results & Final Dividend
2026-02-11 Quarterly Results
2025-11-10 Quarterly Results
2025-08-11 Quarterly Results & A.G.M.
2025-05-29 Audited Results & Dividend
Date Purpose Remarks
2025-09-24 FINAL Rs.1.50 per share(15%)Dividend
View Haleos Labs Dividend History Arrow

Haleos Labs Shareholding Pattern

72.11%
0%
24.33%
3.56%

Haleos Labs FAQs

Haleos Labs share price is ₹1,410 As on 20 June, 2026 | 00:38

The Market Cap of Haleos Labs is ₹426.3 Cr As on 20 June, 2026 | 00:38

The P/E ratio of Haleos Labs is 24.6 As on 20 June, 2026 | 00:38

The PB ratio of Haleos Labs is 2 As on 20 June, 2026 | 00:38

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23